Related Experiment Videos

Endometrial adenocarcinoma associated with drug-induced hyperprolactinemia

P I Ristic, S J Ory, J R Lurain

Obstetrics and Gynecology

|March 1, 1986

Abstract:

A 54-year-old woman with hyperprolactinemia and amenorrhea that occurred with phenothiazine and tricyclic antidepressant use developed a stage IBG2 endometrial adenocarcinoma. This is believed to be the first case reported of endometrial carcinoma associated with drug-induced hyperprolactinemia.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Participation of the general gynecologist in surgical staging of endometrial cancer: analysis of cost and perioperative outcomes.

Gynecologic oncology·2006

Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2003

Evaluating the total costs of chemotherapy-induced toxicity: results from a pilot study with ovarian cancer patients.

The oncologist·2001

Prolonged inhibition of presynaptic catecholamine synthesis with alpha-methyl-para-tyrosine attenuates the circadian rhythm of human TSH secretion.

Journal of the Society for Gynecologic Investigation·2001

Protein kinase C alpha expression is inversely related to ER status in endometrial carcinoma: possible role in AP-1-mediated proliferation of ER-negative endometrial cancer.

Gynecologic oncology·2001

A comparison of post-thaw results between cryopreserved embryos derived from intracytoplasmic sperm injection and those from conventional IVF.

Fertility and sterility·1999

See all related articles